Financing › Details

Kiadis–SEVERAL: investment, 201905 private placment €27.6m with 3.68m new shares at €7.5/share

 

Period Period 2019-05-30 ï¿½ 2019-05-31
Organisation Money taker Kiadis Pharma N.V. (Euronext: KDS)
  Group Kiadis (Group)
Products Product ATIR101™ (Kiadis)
  Product 2 investment banking
Index term Index term CytoSen Therapeutics–Kiadis: investment, 201904– acquisition merger in shares with 1.94m shares (7.4%) upfront plus 5.82 shares milestones
Document Source Kiadis Pharma N.V.. (5/31/19). "Press Release: Kiadis Pharma Raises c.EUR 28 Million in a Private Placement of c.3.7 Million New Shares [Not for US, AU, CA, JP, ZA, et al.]". Amsterdam.
     

   
Record changed: 2019-06-28

Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x91px

More documents for Kiadis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px




» top